Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07122739 · ClinicalTrials.gov registry record · NA

Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy

A NA study of Healthy, sponsored by Trustees of Princeton University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07122739 is a NA study of Healthy that is actively recruiting participants, run by Trustees of Princeton University. The registered enrollment target is 40 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07122739, a NA study of Healthy, is actively recruiting participants, sponsored by Trustees of Princeton University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study tests the efficacy of a new behavioral intervention with the goal of reducing spontaneous recovery of threat expectancy in healthy adults. This real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention delivers feedback based on a functional connection between the prefrontal cortex and the hippocampus.

Conditions Studied

Interventions

  • BEHAVIORAL Active Real-time fMRI Neurofeedback
  • BEHAVIORAL Sham Real-time fMRI neurofeedback

Study Locations (1)

New Jersey

  • Princeton Neuroscience Institute - Princeton

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-17
Est. Completion 2028-06
Phase NA

Sponsor

Trustees of Princeton University

4 total trials

What the Registry Record Tells You About NCT07122739

The ClinicalTrials.gov registry entry for NCT07122739 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Trustees of Princeton University, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Active Real-time fMRI Neurofeedback is the first listed.

NCT07122739 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT07122739 about?

NCT07122739 is a clinical study titled "Neurofeedback to Reduce Spontaneous Recovery of Threat Expectancy". This study tests the efficacy of a new behavioral intervention with the goal of reducing spontaneous recovery of threat expectancy in healthy adults. This real-time functional magnetic resonance imaging (fMRI) neurofeedback intervention delivers feedback based on a functional connection between the ...

What is the current status of trial NCT07122739?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-17. Estimated completion is 2028-06.

What conditions does trial NCT07122739 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT07122739?

The interventions under investigation include: Active Real-time fMRI Neurofeedback (BEHAVIORAL), Sham Real-time fMRI neurofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT07122739?

This trial is sponsored by Trustees of Princeton University, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07122739 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.